BURLINGTON, Mass.--(BUSINESS WIRE)--Dyax Corp. (NASDAQ:DYAX) today announced that the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy designation for the investigation of DX-2930 ...
“Why you can trust Digital Trends – We have a 20-year history of testing, reviewing, and rating products, services and apps to help you make a sound buying decision. Find out more about how we test ...
Selecciona hasta 4 acciones para analizar empresas similares utilizando métricas clave de rendimiento.
Dyax Corp. Presents Phase 1b DX-2930 Data at the American College of Allergy, Asthma, and Immunology Annual Meeting Results Provide Important Clinical Proof-of-Concept, Dose Response and Safety ...
The Acer Aspire 2930 is a relatively compact laptop and is obviously designed for life on the road. Acer says the inspiration for the design has come from its recent Gemstone range (which includes the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results